Value&OutcomesSpotlight Logo

Value & Outcomes Spotlight is an ISPOR publication for the global HEOR community. Value & Outcomes Spotlight provides enhanced content on health policy and methodological issues and independent contributions from the field, as well as the scientific program of ISPOR Annual Meetings/Congresses/Regional Conferences, plus ISPOR news from around the world.

To receive Value & Outcomes Spotlight and other member benefits, join ISPOR.

Current Issue:

Value & Outcomes Spotlight
January/February 2018 Vol. 4, No. 1
Value and Outcomes Spotlight January/February 2017

In this issue of Value & Outcomes Spotlight, we introduce a new layout for 2018, highlighting some new features and sections for our readers to enhance their reading experience. Newly included sections for VOS include ISPOR Central, which includes an ISPOR Speaks section (this issue featuring ISPOR Executive Director & CEO Nancy Berg), and HEOR News and Research Round-Up, which provides the latest in news and research, respectively. The ISPOR Central section also still provides members with future meetings, education, and other ISPOR activities.

As always, VOS continues to strive in providing the most up-to-date topics in HEOR content. We now also begin another new section of sorts in providing a theme for each one of our issues. In this current issue, we focus on Cancer Immunotherapies, with a feature article on the value of these therapies with interviews from prominent leaders in the field such as Michael Drummond, Ravinder Dhawan, and Isao Kamae. We complement this comprehensive piece with related articles on immuno-oncology data, oncology patient-reported outcome measures, and challenges and approaches for overall survival extrapolations, as well as a new “By the Numbers” graphic, contributed by the ISPOR Student Network.

Finally, we publish a Q&A with F. Reed Johnson who led the first FDA sponsored study on patients’ willingness to accept benefit risk tradeoffs for new health technologies on discrete choice experiment methods.

We hope you enjoy the new and improved Value & Outcomes Spotlight! As always, we welcome your feedback and encourage you to email us at

David Thompson, PhD
Value & Outcomes Spotlight Editor-in-Chief